Announcements
- MESA LABS ANNOUNCES AMENDMENT TO CREDIT FACILITY AND REPURCHASE OF SENIOR CONVERTIBLE NOTES
- MESA LABS DECLARES QUARTERLY DIVIDEND
- Mesa Laboratories, Inc. to Announce Unaudited Fourth Quarter and Full Fiscal Year 2024 Results on May 24, 2024
- Mesa Labs Releases Second Annual Responsible Business Program Brochure
- Mesa Laboratories Appoints Mark Capone to its Board of Directors
- Mesa Labs Completes the Acquisition of GKE Science & Technology Co.
- Mesa Laboratories, Inc. to Announce Second Quarter Results on February 5, 2024
- Mesa Labs Acquires GKE-GmbH Complementary Sterilization Indicators and Healthcare Channels to Mesa’s SDC Platform
- Mesa Laboratories, Inc. to Announce Second Quarter Results on November 6, 2023
- Mesa Laboratories, Inc. Announces Commitment to Disclose Scope 1 and 2 Greenhouse Gas Emissions
More ▼
Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 104.00 |
---|---|
High | 104.00 |
Low | 104.00 |
Bid | 104.00 |
Offer | 108.00 |
Previous close | 102.00 |
Average volume | 0.00 |
---|---|
Shares outstanding | 5.39m |
Free float | 5.08m |
P/E (TTM) | 647.31 |
Market cap | 611.52m USD |
EPS (TTM) | 0.1751 USD |
Data delayed at least 15 minutes, as of May 03 2024 08:31 BST.
More ▼